Actively Recruiting
Percutaneous Transluminal Angioplasty Registry
Led by Klinik für Kardiologie, Pneumologie und Angiologie · Updated on 2020-02-07
1000
Participants Needed
1
Research Sites
834 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.
CONDITIONS
Official Title
Percutaneous Transluminal Angioplasty Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing PTA
You will not qualify if you...
- Younger than 18 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, Germany, 40225
Actively Recruiting
Research Team
C
Christian Heiss, MD
CONTACT
R
Rabea Wagstaff, BSc., M.A.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here